Under way, not recruiting
New Treatment Modalities for Localized Prostate Cancer
NCT05523856 · Fundacion IMIM · Updated 12 March 2025
- What is being tested
- Active Surveillance; Robot-Assisted Radical Prostatectomy; Intensity-Modulated Radiotherapy; Real-time brachytherapy
- For
- Prostate Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 50 years to 75 years. About 480 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started April 2014, ends Dec 2027. Registered 31 Aug 2022.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to evaluate the effectiveness of four of the nowadays most established primary treatments for patients with clinically localized prostate cancer (active surveillance, robot-assisted radical prostatectomy, intensity-modulated radiotherapy, and real-time brachytherapy) at short-, mid- and long-term follow-up. The primary aim is assessing the impact of treatments' side effects on patient's quality of life. As secondary objectives, biochemical disease-free survival, overall survival, and prostate cancer-specific survival will also be assessed.